Diagnostic laboratories of IMD, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Am J Med Genet A. 2022 Jul;188(7):1979-1989. doi: 10.1002/ajmg.a.62728. Epub 2022 Mar 26.
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the GLA gene encoding alpha-galactosidase A (AGAL). The impact of X-chromosome inactivation (XCI) on the phenotype of female FD patients remains unclear. In this study we aimed to determine pitfalls of XCI testing in a cohort of 35 female FD patients. XCI was assessed by two methylation-based and two allele-specific expression assays. The results correlated, although some variance among the four assays was observed. GLA transcript analyses identified crossing-over in three patients and detected mRNA instability in three out of four analyzed null alleles. AGAL activity correlated with XCI pattern and was not influenced by the mutation type or by reduced mRNA stability. Therefore, AGAL activity may help to detect crossing-over in patients with unstable GLA alleles. Tissue-specific XCI patterns in six patients, and age-related changes in two patients were observed. To avoid misinterpretation of XCI results in female FD patients we show that (i) a combination of several XCI assays generates more reliable results and minimizes possible biases; (ii) correlating XCI to GLA expression and AGAL activity facilitates identification of cross-over events; (iii) age- and tissue-related XCI specificities of XCI patterning should be considered.
法布雷病(FD)是一种 X 连锁溶酶体贮积症,由编码α-半乳糖苷酶 A(AGAL)的 GLA 基因突变引起。X 染色体失活(XCI)对女性 FD 患者表型的影响尚不清楚。在这项研究中,我们旨在确定 35 名女性 FD 患者队列中 XCI 检测的陷阱。通过两种基于甲基化的和两种等位基因特异性表达测定法评估 XCI。结果虽然存在一些差异,但相互关联。GLA 转录分析在 3 名患者中发现了交叉互换,并在 4 个分析的无义等位基因中的 3 个中检测到了 mRNA 不稳定性。AGAL 活性与 XCI 模式相关,不受突变类型或降低的 mRNA 稳定性影响。因此,AGAL 活性可能有助于检测不稳定 GLA 等位基因患者的交叉互换。在 6 名患者中观察到组织特异性 XCI 模式,在 2 名患者中观察到年龄相关的变化。为避免对女性 FD 患者的 XCI 结果产生误解,我们表明:(i)结合几种 XCI 测定可产生更可靠的结果,并最大程度地减少可能的偏差;(ii)将 XCI 与 GLA 表达和 AGAL 活性相关联有助于识别交叉事件;(iii)应考虑 XCI 模式的年龄和组织特异性。